Glycemic control with regular versus lispro insulin sliding scales in hospitalized Type 2 diabetics

Journal of Diabetes and Its Complications
Abel AlfonsoRobert A Vigersky

Abstract

The aim of this study was to compare glycemic control with either regular or lispro insulin sliding scales in hospitalized Type 2 diabetics who were not using insulin as outpatients. Forty-three patients with Type 2 diabetes, who were taking oral agents only, were admitted to a medical inpatient service and randomized to receive either regular or lispro insulin sliding scale. Oral agents for diabetes were held upon admission and patients were followed throughout their hospital stay. There was no significant difference (P>.05) between the average finger-stick blood glucose (FSBG) in the regular insulin group (157.78+/-40.16 mg/dl) and the lispro insulin group (152.04+/-27.71 mg/dl). No significant difference was found between the daily dose of insulin (regular, 5.83+/-5.01 units; lispro, 4.27+/-3.40 units), total amount of insulin used during hospitalization (regular, 11.87+/-10.78 units; lispro, 12.77+/-14.39 units), glucose excursion (regular, 110.13+/-25.86 mg/dl; lispro, 106.77+/-52.65 mg/dl), or length of hospital stay (regular, 2.33+/-1.23 days; lispro, 2.69+/-1.59 days). No significant difference in glycemic control was found in hospitalized Type 2 diabetic patients who received either regular or lispro insulin sliding sc...Continue Reading

References

Apr 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·L KiersS Ratnaike
Aug 1, 1981·Anesthesiology·L F WaltsJ Brown
Mar 10, 1997·Archives of Internal Medicine·C T Sawin
Dec 31, 1997·Archives of Internal Medicine·D S Trochtenberg
Feb 24, 1998·Archives of Internal Medicine·R M BergenstalS List
Jul 20, 2001·International Journal of Cardiology·J BolkV A Umans
Oct 6, 2001·Stroke; a Journal of Cerebral Circulation·S E CapesH C Gerstein
Jan 17, 2002·The New England Journal of Medicine·G van den BergheR Bouillon
Mar 13, 2002·The Journal of Clinical Endocrinology and Metabolism·Guillermo E UmpierrezAbbas E Kitabchi
Apr 10, 2002·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Lawrence J MarkovitzSusan S Braithwaite
Oct 4, 2002·The American Journal of Medicine·Lee N MetchickUNKNOWN Section of Endocrinology, Department of Medicine, Yale Universtiy School of Medicine, New Haven, Connecticut
Mar 1, 2003·Diabetes Care·Paul HoganUNKNOWN American Diabetes Association

❮ Previous
Next ❯

Citations

Oct 14, 2006·Diabetes Technology & Therapeutics·Irl B Hirsch
Sep 3, 2009·World Journal of Gastroenterology : WJG·Takehiro OkabayashiKazuhiro Hanazaki
Mar 8, 2014·World Journal of Gastroenterology : WJG·Lesley De PietriBruno Begliomini
Oct 7, 2011·World Journal of Surgery·Takehiro OkabayashiKazuhiro Hanazaki
Jul 31, 2009·The Journal of Hospital Infection·T OkabayashiK Hanazaki
Apr 14, 2007·Clinics in Podiatric Medicine and Surgery·John M GiuriniJeremy J Cook
Mar 14, 2014·Diabetes Care·Takehiro OkabayashiKazuhiro Hanazaki
Jun 2, 2010·Journal of Diabetes Science and Technology·Melissa E WeinbergRobert J Rushakoff
Nov 30, 2018·The Cochrane Database of Systematic Reviews·Luis Enrique Colunga-LozanoCarlos A Cuello-García
Mar 20, 2015·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Kavita SinghDavid Moher
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.